Search results
Riding for a cause: One Mainer's journey doing the Pan-Mass Challenge
WCSH 6 Portland· 7 days agoAccording to the Dana-Farber Cancer Institute, its cancer hospital was ranked #4 globally—the only...
How to reduce health care’s climate impact? Increase telehealth
GBH News· 7 days ago“Tele-medical and decentralized cancer care does provide a large relative reduction in emissions,”...
Pilot Study in JNCCN Explores New Approach for Reducing Anxiety and Improving Quality of Life after...
The Woonsocket Call· 3 days agoResearchers at Brigham and Women's Hospital and Dana-Farber Cancer Institute found significant uptake and scalability ...
Andover and North Andover residents ride to raise money for cancer research
The Eagle-Tribune· 6 days agoCyclists from both towns — 56 in all — will participate in the Pan-Mass Challenge, a bike-a-thon...
Portsmouth breast cancer survivor celebrates National Cancer Survivor Month through giving back
Portsmouth Herald via Yahoo News· 2 days agoIt’s a defiance of cancer on all...pediatric patient care and cancer research at the nation’s...
Hartford hosts the 2nd annual Ang’s Warrior Walk for Lung Cancer Awareness
WTNH-TV New Haven· 4 days agoHARTFORD, Conn. (WTNH) – Two sisters honored their mother this weekend by hosting a fundraiser for...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoPRESS RELEASE Nature's Scientific Reports publishes an article describing the quantification of novel radio-enhancer AGuIX® developed in brain metastases Confirmation, consistently with already published1 observations, of AGuIX® ability to act
One Patient Changed This Onc's View of Hope. Here's How.
Medscape· 2 days agoOne Patient Changed This Oncologist's View of Hope. Following a stem cell transplant for leukemia,...
Area briefs: Goshen nurse honored; Bikes Fight Cancer ride; water to be shut down on part of...
Daily Hampshire Gazette· 3 days agoState Rep. Lindsay Sabadosa and state Sen. Paul Mark recognized Goshen resident and state employee...
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with...
KSAN - KLST San Angelo· 3 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...